Annals of Clinical and Translational Neurology · 2019 · 30 citations · 11 references
Life SciencesNeurologyPathologyImmunotherapyNeuroimmunologyNeuropathologyAutoimmune Neurological DisordersCentral Nervous System TumorsDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisDemyelinating Lesion PathologyHistopathological ResponseImmune-mediated DemyelinationMog Antibody DiseaseMog Antibody-associated DiseaseMultiple Sclerosis PathologyMyelin-associated GlycoproteinRituximab-based Therapy
Our objective was to examine the brain biopsies by histopathology and investigate the prognosis of patients with myelin oligodendrocyte glycoprotein antibody-associated demyelinating pseudotumor. The clinical, MRI, and histological features of two patients with myelin oligodendrocyte glycoprotein antibody-associated demyelinating pseudotumor were reviewed. Both patients were treated with steroid plus rituximab and followed up. The brain biopsies of both cases revealed T cells, macrophages, and complement-mediated demyelination, which was in accord with multiple sclerosis-like pathology. Moreover, both cases showed favorable response to steroid plus rituximab therapy. Our cases add a new variant to the myelin oligodendrocyte glycoprotein-encephalomyelitis spectrum, which favorably responds to immunotherapy.
11
Sven Jarius, Klemens Ruprecht, Ingo Kleiter et al. · Journal of Neuroinflammation · 2016 · 891 citations · Full text
Medicine, Neurology, Neuroscience +15